Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT Experience.

Background: Precision oncology uses molecular profiling of tumors to identify biomarker-tailored therapies for patients in the hope of improving outcomes. Typically, only a minority of patients receives evaluable matched treatment. This study explored the reasons for attrition on a precision medicine trial.